Prevision Policy

@PrevisionPolicy

Breaking analysis for biopharma

Washington, DC

Joined February 2010

60 Following

90 Followers

62 Posts

Prevision Policy @PrevisionPolicy

over 8 years ago

Early #Alzheimer's Disease revised draft guidance https://t.co/m9A8DmpKKs

0

0

0

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

#Epilepsy: Partial onset seizures draft guidance https://t.co/QpMjfNcbKx

0

0

0

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

Duchenne Muscular Dystrophy final guidance https://t.co/mC1ajZ57qN

0

0

0

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

Draft Amyotrophic Lateral Sclerosis guidance https://t.co/CCbXcwqubr

0

0

0

0

0

Who to follow

Kate Rawson Powell

Drug regulation/health policy journalist, downhill skier, cyclist, Mom to two, school choice supporter, library lover, Baltimore believer. Tweets are all me.

Foundation for FDA

The Reagan-Udall Foundation for the FDA is an independent non-profit created by Congress to advance regulatory science critical in supporting @US_FDA's mission.

Michael McCaughan

Founding Member, Prevision Policy LLC Business Implications of FDA and CMS Policy; Policy Implications of Biopharma Business

Prevision Policy @PrevisionPolicy

over 8 years ago

#Migraine: Developing drugs for acute treatment https://t.co/CjiRO4keHo

0

0

0

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

Akcea’s Volanesoren AdComm May 10

0

0

0

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

Pre-Request for Designation final guidance https://t.co/ICMWzifQUQ

0

0

0

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

ICER Spark’s Luxturna #GeneTherapy report https://t.co/wCk7MUJfJH

0

0

1

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

.@Amgen’s Blincyto sBLA to Oncologic Drugs AdComm March 7

0

0

1

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

Regulatory classification of #pharmaceutical co-crystals guidance https://t.co/W5NypeFrcZ

0

0

0

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

Exparel Ad Comm briefing docs https://t.co/kNiuddNKun

0

0

0

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

Hydexor Ad Comm briefing docs https://t.co/qL3AXNjyLD

0

0

0

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

#CBER's Vaccines and Related Biological Products AdComm March 1

0

0

0

0

0

PrevisionPolicy retweeted

over 8 years ago

This month’s #340BConf will feature the seasoned pro Michael McCaughan @RPMReportMike of @PrevisionPolicy on what to expect in year two of the Trump era.

340BCoalition's tweet photo. This month’s #340BConf will feature the seasoned pro Michael McCaughan @RPMReportMike of @PrevisionPolicy on what to expect in year two of the Trump era. https://t.co/oOl73EeDdw

0

2

4

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

.@US_FDA's Office of Generic Drugs 2017 report https://t.co/mZlrLiVMtc

0

0

1

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

.@GileadSciences’ triple combo #HIV treatment Biktarvy gets FDA approval #PvPClips

0

0

0

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

Product-Specific Bioequivalence ANDA Guidances https://t.co/8k9Hpp68n8

0

0

1

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

.@ExpressScripts #drugspending report released https://t.co/0XJLpGHLu2

0

0

1

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

New CBER-CDER Data Standards Strategy https://t.co/0ZYqhEOpDj

0

0

1

0

0

Prevision Policy @PrevisionPolicy

over 8 years ago

.@Zogenix’ #SeizureTherapy gets FDA Breakthrough Designation #PvPClips

0

0

1

0

0

Last Seen Users on Sotwe

Trends for you

Most Popular Users